Events I Witnessed, News You Made, & People We Met
The year 2010 was all about me. By 'me' I mean Pharmaguy, which is the Twitter handle and Facebook name of John Mack, Editor and Publisher of Pharma Marketing News. It's all about YOU too! This is where you can 'sign' the 2010 Pharma Marketing Yearbook and and document that you were part of it all.
Pharma Marketing News Vol. 10, No. 10: 8 June 2011
Welcome to Volume 10, Issue #10 (8 JUNE 2011) of Pharma Marketing News.
A New Estimate of Drug Development Cost
Economic Experts Disagree Wildly on How Much It Costs to Bring a New Drug to Market. How is it that the Tufts estimate is at least 14 TIMES the London School of Economics and Political Science (LSEPS) estimate? 'Make no mistake,' said Tufts. 'Tufts CSDD will vigorously defend the scholarship, integrity, and validity of all its published research studies.'
Welcome to the 2010 Pharma Marketing YearBook™
Welcome to Volume 10, Issue No. 1 (Jan 12, 2011) of Pharma Marketing News. This issue of Pharma Marketing News is devoted to the Pharma Marketing Yearbook (PMY), which is a commemorative record of pharmaceutical marketing issues and highlights of the past year.
The Changing Pharma eDetailing Landscape
A conversation with Monique Levy, VP Research at Manhattan Research, about the changing pharma eDetailing landscape. Ms. Levy discusses how the online pharma promotion landscape has changed, and which types of programs garner the largest audience as well as how the rep relationship is evolving and the role of new technologies such as tablets.
FDA Drops Social Media from Its Guidance Agenda: Focuses Instead on Responsding to “Unsolicited”...
FDA's revised draft guidance calendar for year 2011 is missing 'Promotion of Prescription Drug Products Using Social Media Tools,
The Digital Health Coalition: Solving Real Problems — Mission Possible?
A conversation with Mark Bard, founder of the Digital Health Coalition, regarding the mission of the Coalition and what companies and individuals are involved.
Are Sales Reps as “Useful” as PhRMA Wants Us to Believe?
Let's Look at Some Data PhRMA Doesn't Mention. PhRMA pointed out that nearly 9 out of 10 physicians considered company-sponsored peer education programs to be 'up-to-date, useful and reliable.'
Orphan Drugs Now “Where the Money Is,” Says Willie Sutton’s Ghost
Why do pharma companies bother developing drugs for for a disorder affecting fewer than 200,000 people? Willie Sutton's ghost may have the answer.
Pharma’s Physician Bailout
The pharmaceutical industry has been very generous in making payments to physicians. Last year (2010), for example, a mere dozen pharmaceutical companies paid $760 million to physicians and other health care providers for consulting, speaking, research and expenses. On average, how much do you think that comes to for every physician in the U.S.?
